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Factors associated with concurrent illicit use of opiates and crack/cocaine among opiate-users in 
Treatment: Implications for treatment services in England.   
 
Abstract: 
 
Background: The aim of this study was to identify factors associated with concurrent illicit drug use of opiates 
and crack/cocaine use among individuals receiving of opioid medication-assisted treatment (MAT) in one 
English rural/urban County Council area.  
Methods: 776 opiate users in treatment were assessed using the Addiction Dimensions for Assessment and 
Personalised Treatment (ADAPT) assessment tool (Marsden et al, 2014). The tool encompasses three domains 
and 14 subdomains covering addiction severity, recovery strengths and coexisting health and social needs. Data 
were opportunistically matched to the National Drug Treatment Monitoring System (NDTMS) and the 
Treatment Outcome Profile (TOP). Two backward stepwise logistic regression models were run to discern the 
nature of concurrent illicit drug use.  
Results: Addiction severity (Odds Ratio [OR] 12.55, Confidence interval [CI] 6.49-24.27), low recovery 
strengths (OR 2.30, CI 1.30-4.07) and no µurge/control¶ (OR 27.45, 13.18-57.16) were strongly associated with 
concurrent use. Individuals with moderate psychological needs were more likely to be abstinent (OR 2.97, CI 
1.67-5.29) compared to those with no need. Abstaining from injecting (OR 2.38, CI 1.15-4.93), alcohol 
consumption (OR 1.55, CI 1.05-2.30), increasing age (OR 1.03, CI 1.01-1.06) and increased quality-of-life (OR 
1.05, CI 1.00-1.10) were associated with abstinence from concurrent use. 
Conclusion:  Practitioner assessments with self-report data offer unique perspectives RQVHUYLFHXVHUV¶KROLVWLF
needs. Interventions addressing concurrent use during MAT should consider managing urges and control of 
illicit Class A use, injecting and alcohol consumption within a stepped-care approach. Packages for developing 
recovery strengths supporting psychological need and enhancing quality-of-life is recommended.  
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1. Introduction 
 
Chronic drug use will often lead to problematic health conditions (Stein, 1990) alongside social consequences 
such as financial difficulties, unemployment, homelessness, criminality, the breakdown of families or 
friendships or comorbid mental health problems (Hammersley et al, 2007; Craig & Hodson, 2000; Reid & Klee, 
1999). Studies have consistently shown that problematic heroin and crack or cocaine misusing individuals make 
significant improvements in curtailing illicit drug use and criminality following treatment (Jones et al, 2009; 
Gossop et al, 2003; Anglin et al, 1997; Hubbard et al, 1997; Simpson, 1990). Improvements to physical and 
psychological health have also been noted (Teeson et al, 2008; Gossop et al, 2002).  
 
The importance of identifying factors that promote reductions in illicit drug use therefore are pivotal in 
determining a positive treatment outcome. Service users who can avoid continued use of Class A substances 
have been shown to have better outcomes (Litt et al, 2003; Gossop et al, 2002) allied to length of stay in 
treatment (Jones et al, 2009; Hubbard et al, 2003; Simpson et al, 1997).  Sustained use of stimulants whilst 
simultaneously in receipt of opioid medication-assisted treatments (MAT) has been viewed as associative with 
unemployment and criminal activities (Darke et al, 2005; Hser & Anglin, 1998; Magura et al, 1998; Grella et al, 
1997). Understanding the defining characteristics of concurrent drug use has been shown to be problematic 
(Beswick et al, 2001; Grella et al, 1997) due to changing dosage levels (Mattick et al, 2007; Best et al, 1999; 
Hartel et al, 1995). Low coping efficacy has also been shown to be a predictor of continued use whilst in receipt 
of MAT often as means to manage withdrawal symptoms (Best et al, 1999; Senbanjo et al, 1999).  A meta-
analysis (Brewer et al, 1998) identified factors associated with concurrent use of illicit substances during 
treatment that included the extent of previous episodes of abstinence relating to drug and alcohol use, the 
severity of drug-using prior and whilst in treatment, mental health factors encompassing depression and stress, 
unemployment, exposure to drug-using peers and treatment factors including the extent of previous engagement 
with services.  
 
In the UK, treatment provision has been encouraged to become more µrecovery-oriented¶ZKLOVW accepting a role 
for MAT (typically comprising methadone and buprenorphine) as part of a holistic package to facilitate recovery 
(National Treatment Agency, 2012). Although improvements in health-related issues and interpersonal 
relationships may occur despite continued use of substances whilst in treatment (Laudet & White, 2010; 
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Donovan et al, 2005) individuals in long-term, stable recovery are more likely to report high rates of self-
efficacy and are able to manage a range of social problems (Hser, 2007). Services have incorporated concepts of 
UHFRYHU\ LQWR D ³JHQHUDO ZHOOQHVV´ RULHQWDWHG GHVFULSWLRQ (Hser, 2007; Rudolf & Watts, 2002), referring to a 
voluntary and continued control over substance use, that considers housing, employment and other social needs 
(Laudet, 2007; Timpson et al, 2006). Recovery strengths can be viewed as synonymous with cross-disciplinary 
strengthen-based approaches which have been shown to establish a wide range of positive outcomes (Pattoni, 
2012). Although the pathways to recovery are complex (Best et al, 2008), there remains a need to link 
appropriate interventions to an LQGLYLGXDO¶VFOLQLFDOand social needs to help promote recovery (Thornton et al, 
2008) including matching interventions to WKH H[WHQW RI DQ LQGLYLGXDO¶V addiction (Timko & Sempel, 2004; 
McKellan et al, 1997).  
The aim of this study is to examine factors that are associated with concurrent use of illicit opiate and/or cocaine 
among a treatment population in receipt of MAT. It is hypothesized that there are factors associated with 
continued use of street opiates and cocaine that encompass complex interactions between the nature of an 
LQGLYLGXDO¶V DGGLFWLRQ and their interrelated health or social problems. %UHZHU HW DO¶V  OLVW RI SRWHQWLDO
factors suggest a range of areas for consideration inclXGLQJH[DPLQLQJWKHH[WHQWDQGQDWXUHRIDQLQGLYLGXDO¶V
drug and alcohol use, comorbid mental health problems and social factors such as unemployment. Identification 
of factors associated with concurrent Class A drug use will aid the development of a holistic recovery-orientated 
response.  
 
The study reports on an opportunistic data linkage study matching an assessment of a VXEVDPSOHRIRQHDUHD¶V
MAT SRSXODWLRQ¶V holistic needs using a clinical assessment tool, the Addiction Dimensions for Assessment and 
Personalised Treatment (ADAPT) that has been shown to describe the wide range of clinical, social and other 
recovery-orientated issues associated with treatment engagement, with self-reported needs derived from the 
National Drug Treatment Monitoring System (NDMTS) and the Treatment Outcome Profile (TOP) to describe 
the nature of concurrent illicit opiate and cocaine use.  
 
 
2. Method 
 
2.1 Setting 
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The study was conducted across publicly funded specialist treatment services in one mixed rural/urban County 
Council area in England. The services offered a range of clinical and psychosocial support encompassing mainly 
methadone and buprenorphine prescribing including detoxification packages and one to one support including 
counselling, structured or peer-led group work. Treatment services adhered to a broad recovery model ensuring 
wellness and stability whilst encouraging reductions in illicit drug use.  For the purpose of this study, a subset of 
the wider treatment population was established based on whether they received MAT. There was limited 
additional information within the available datasets that allowed for a deeper analysis (for example, by dosage).  
 
2.2 Measures 
 
The Addiction Dimensions for Assessment and Personalised Treatment (ADAPT) is a validated 14-item multi-
dimensional schedule (Marsden et al, 2014) examining three domains describing µaddiction severity¶WROHUDQFH
and withdrawal, urge and control, overdose risk), µhealth and social complexity¶ SK\VLFDO SV\FKRORJLFDO
personality, relationships, risk to self and others, housing, finance) and µrecovery strengths¶ (motivation, outlook 
and management, social network support, skills and participation) . The tool was chosen as a non-intrusive 
means of capturing the holistic needs of individuals in treatment to support the care-planning process at the 12-
week point. ADAPT was selected as an appropriate tool by the treatment provider from other alternative 
options. The aim of ADAPT is to assist with the assessment and treatment planning process by matching clients 
to an appropriate intervention type (Marsden et al, 2014).  
The items were scored on a binary µno problem¶ (0) or µproblem identified¶ (1) scale for five questions relating 
to tolerance/withdrawal, overdose risk, physical health, housing and finance needs. The remaining questions 
were scored on a four-point Likert scale reporting µno issue¶ (0)µlow¶ (1), µmoderate¶ (2) RUµhigh¶ (3) needs. 
The individual scores for each component were aggregated into the three overarching domains by adding up the 
FRPSRVLWHVFRUHVVRWKDW¶ORZ¶QHHGLVmeasured between 0 and 1 for addiction severity, 0 and 2 for coexisting 
problem complexity and 0 and 5 IRUUHFRYHU\VWUHQJWKVµ0RGHUDWH¶QHHGVVFRUHEHWZHHQDQGIRUDGGLFWLRQ
severity, 3 and 5 for coexisting problem severity and 6-8 for recovery strengths. Scores of between 4 and 5 for 
addiction severity, 6-15 for coexisting problem severity and 9 to IRUUHFRYHU\VWUHQJWKVLQGLFDWHµKLJK¶OHYHOV
of need.  
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The use of these measures was based on practitioner perceptions of need, and were originally calculated to 
reflect include age, gender, nature of illicit drug use, treatment received including length of time in treatment 
(Mardsen et al, 2014).  
 
The Treatment Outcome Profile (TOP) is a self-report outcome measurement system embedded within the 
National Drug Treatment Monitoring System (NDTMS), a national (England and Wales) public health 
surveillance system. TOP gathers information about service users: current illicit drug use (prescribed medication 
is not captured); injecting behaviours (yes/no); criminal activity; a µhealth and social functioning¶FRPSRQHQW
that encompasses psychological and physical health, housing, employment and an assessment of quality of life 
(Marsden et al, 2008).  Socio-demographic information on the treatment population were reported using 
NDTMS and levels of abstinence or concurrent drug use were captured through linking with the care-planning 
review process integrating the use of TOP. TOP is completed as part of care planning and is usually competed in 
12-week cycles or at the point of discharge. For this study, 93% (n=719) of the TOP data were collected at 12-
weeks from initial assessment. Concurrent opiate use therefore was calculated using TOP recoded as a 
dichotomous variable. The ADAPT assessment was applied to all clients in treatment identified as receiving 
MAT as of April 2017. Casefiles on clients were reviewed by their respective drug treatment worker. The 
assessment process was undertaken without interviewing clients directly but rather based on keyworker staff 
SHUFHSWLRQVRIWKHLUFOLHQWV¶DGGLFWLRQ-severity, health and social complexity, and recovery strengths. 
 
The combined use of self-report and a practitioner assessment provides a test for response concordance, but also 
presents a view of DVHUYLFHXVHU¶VKROLVWLFQHHGVbased on the strength of the client-worker relationship where a 
worker can adequately and dispassionately assess DQLQGLYLGXDO¶Vclinical and social needs.  This increases the 
accuracy of responses and allows for an overview across a caseload by comparing VHUYLFHXVHUV¶QHHGVWRHQVXUH
consistency.  To support consistency in how workers completed ADAPT, training sessions were delivered with 
ongoing support was provided by senior management.  ADAPT data was captured on a bespoke spreadsheet and 
matched to NDTMS and TOP data using unique and anonymised client reference numbers. 
 
  
 
2.3 Statistical Analysis 
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The subsequent analysis was undertaken on Stata v14. An initial exploration of NDTMS and TOP data was 
undertaken to check for coverage. Variables were included that met a coverage threshold of no less than 10%. 
Two questions coexisted across ADAPT, TOP and NDTMS relating to injecting status and housing needs and 
were assessed for concordance. 7KHVHUHODWHGWRZKHWKHUDVHUYLFHXVHULQMHFWHGLQDELQDU\µ\HVQR¶DQVZHU, and 
an ordinal question differentiating between broad housing needs and reporting no-fixed abode. These questions 
were answered by the same practitioner and reflect their knowledge of their caseload at that point in time. These 
questions were found to have 100% percentage concordance across the three formats, which is likely to be due 
to the relative proximity between completing ADAPT and NDTMS/TOP records. It is possible that practitioners 
were influenced by knowledge of completing separate schedules with the same information, but discussions 
with the service provider suggested that practitioners provided an DFFXUDWHDVVHVVPHQWRIVHUYLFHXVHU¶VLQMHFWLQJ
and housing status at these points in time.  Consequently, the ADAPT measure was utilised for data analysis. 
Following an initial exploratory phase, a binary logistic regression was used to model concurrent use of opiate 
and crack/cocaine with 14 prognostic variables available for inclusion: use of alcohol and cannabis (TOP), 
injecting (TOP), previous treatment history (NDTMS), age (NDTMS), gender (NDTMS), ethnicity (NDTMS), 
self-referral (NDTMS), criminal justice referral (NDTMS), quality of life (TOP), paid work (TOP) and three 
ADAPT domains addiction severity score rank, recovery strengths score rank and coexisting problem 
complexity score rank. 
 
A separate model was created using the same outcome variable (concurrent use versus abstinence), TOP and 
NDTMS prognostics and the 14-item subsections that comprise the three ADAPT domains to derive greater 
specificity. In this second modelling exercise, the same 14 prognostic variables were evaluated for inclusion, 
together with the 14 individual subdomains of the ADAPT framework. The two binary regression models were 
ILWWHG WR PRGHO WKH GLFKRWRPRXV RXWFRPH µ$EVWLQHQW Opiate Crack Cocaine¶ $ SURJQRVWLF ZDV GHFODUHG
³VWDWLVWLFDOO\ VLJQLILFDQW´ LI LWV S-value =< 0.05 (working at 5% significance). A backward stepwise selection 
method was used for all prognostics shown above. Seven variables were statistically associated with a change in 
the odds of not using opiates or crack cocaine whilst in treatment. 
 
 
2.4 Approvals & Ethics 
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An application was made to the NHS Health Research Authority that stated that this study fell within the 
µVHUYLFHHYDOXDWLRQ¶GHILQLWLRQ. Identifiable data only held by the treatment provider and this paper is based on 
secondary interrogation of anonymised data. 
 
3. Results 
 
3.1 Description of the Treatment Population 
 
776 individuals were identified as in receipt of MAT as of April 2016. The characteristics of participants are 
shown in Table 1. Nearly three-quarters of the population were male (73%, n=563); with a mean age of 40.7 
years (range 19-70 years, standard deviation 7.89) and 94% were recorded as being of white British ethnicity. 
Over half of the cohort were self-referrals (59%, n=459) with just under one-fifth (19%, n=147) referred via the 
criminal justice system.  
 
[insert Table 1 about here] 
 
Just under one-fifth (19%) of the cohort ZHUHLGHQWLILHGE\VWDIIDVKDYLQJµKLJK¶OHYHls of addiction severity and 
coexisting health and social problems (Table 2). 41% were also identified as having a low level of addiction 
severity and just over half (51%) were reported as having low levels of need in relation health and social 
problems. B\ZD\RIFRQWUDVWZHUHVKRZQWRKDYHµKLJK¶OHYHOVRIUHFRYHU\VWUHQJWKVZLWKUHSRUWHGDV
DWDµORZ¶OHYHO 
 
[insert Table 2 about here] 
 
Despite receiving MAT, only 38% of the cohort were abstinent from opiate and crack/cocaine use. Just under 
three-quarters (73%, n=563) were reported as not using alcohol and 87% (n=675) were not reporting using 
cannabis at follow-up. 89% (n=687) of the cohort also reported not injecting drugs at the point of the TOP 
review. The first model (Table 3) suggested a strong relationship between continued use of opiates and crack or 
cocaine whilst in treatment and the extent of addiction severity as measured by the ADAPT tool, with a less 
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pronounced relationship with concurrent illicit drug use and DQLQGLYLGXDO¶Vrecovery strengths. In comparison to 
DµKLJK¶VFRUH reporting DµORZ¶addiction severity score was associated with an Odds Ratio (OR) of 12.55, 95% 
Confidence Interval [CI]) [6.49, 24.27] VXJJHVWLQJ WKDW µORZ¶VHYHULW\ZLOO LQFUHDVH WKHRGGVRIDEVWLQHQFHE\
over WLPHVWKDWRIVHUYLFHXVHUVZLWKµKLJK¶OHYHOVRIVHYHULW\This is in comparison to individuals who will 
be twice as OLNHO\ WREHDEVWLQHQW LI WKHLUDGGLFWLRQVHYHULW\ LV µPRGHUDWH¶FRPSDUHG WRµKLJK¶ 25 95% 
[1.30, 4.77]).   
 
There is also an association between service users with higher reported recovery strengths and not using illicit 
drugs concurrently. Individuals UHSRUWLQJµKLJK¶ OHYHOVRI UHFRYHU\VWUHQJWKVZHUH shown to be twice as likely 
(OR 2.30; 95%, [1.30, 4.07]) to report abstaining from opiate or crack/cocaine use relative to a low score. The 
relationship between not using opiate and crack/cocaine with the ADAPT domains became more nuanced when 
considering the effect of health and social coexisting problems.  Contrary to what one may expect, individuals in 
MAT ZLWK µPRGHUDWH¶ DQG µKLJK¶ FRH[LVWLQJ KHDOWK DQG VRFLDO SUREOHPV ZHUH PRUH OLNHO\ WR EH DEVWLQHQW
compared to individuals with no needs. Those in MAT were twice as likely to report not using opiates and 
crack/cocaine LIWKH\UHSRUWµKLJK¶25&,RUµPRGHUDWH
25&,
health and social coexisting problems compared to a low score. 
 
Other indicators derived from TOP were associated with abstinence from use of opiate and crack/cocaine. 
Current levels of injecting predicted abstaining from opiate and crack/cocaine (OR 2.38; 95%; [1.15, 4.93]) as 
did abstaining from alcohol (OR 1.55; 95%; [1.05, 2.30]). Two additional numerical prognostics were shown to 
be associated with abstinence)LUVWO\DµTXDOLW\RIOLIH¶PHDVXUHGHULYHGIURPD-20 Likert scale using TOP) 
shows for every 1-SRLQWLQFUHDVHLQDQLQGLYLGXDO¶VTXDOity of life measure there is a 5% relative increase in the 
odds of being abstinent from use of opiate or crack/cocaine drugs (OR 1.05; 95% CI; 1.0, 1.10). Secondly, 
increasing age was also shown to be associated with no longer using opiates and crack/cocaine (OR 1.03; [1.01, 
1.06]) although it should be noted that the effect sizes for these two prognostics were small. 
 
[insert Table 3 about here] 
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A second logistic regression model (Table 4) examined associations between abstaining from opiate and crack/ 
cocaine and the 14-items subdomains (excluding the main ADAPT domains). Five variables were associated 
with a change in the odds of abstaining from using opiate and crack/cocaine. Service users with no reported 
µurge¶ µXUJHDQGFRQWURO¶VXE-domain) to use were shown to 27 times more likely to be abstinent compared to 
users with a µstrong and persistent desire¶ to use, although the wide confidence levels should be noted (OR 
27.45; [13.18, 57.16]).  
 
Psychological health which forms the coexisting problem complexity domain was also a significant factor. 
Perhaps counter-intuitively, individuals with µKLJK¶ OHYHOV RI QHHG LQ UHODWLRQ WR SV\FKRORJLFDO KHDOWK ZHUH
shown to be five times more likely to be abstinent compared to having µno¶ psychological health issues (OR 
5.36; [1.09, 26.36]). Caution is advised in the interpretation of this finding due to the wide confidence level 
shown. Individuals were twice as likely (OR 2.00; [1.3, 3.1]) if they reported µORZ¶ OHYHOVRI QHHG DQG three 
times as likely (OR 2.97; [1.67, 5.29]) to be abstinent if a service user stated µPRGHUDWH¶ needs. As with the 
previous model examining the three domains, injecting status (OR 2.58; [1.21, 5.49]), quality of life (OR 1.06, 
[1.02, 1.11]) and age (OR 1.03; [1.0, 1.1]) were also shown to be associated with abstinence from opiate and 
crack/cocaine use although the effect sizes for the latter two prognostics were relatively small.  
 
[insert Table 4 about here] 
 
4. Discussion 
 
The findings highlight the relative importance of treating addiction severity DQG WKH µXUJH DQG FRQWURO¶ 
subdomain as a corollary to concurrent illicit opiate and crack/cocaine use which confirms previous research 
(Brewer et al, 1998). The ability to control urges and cravings are often cited as a predictor of relapse (Verheual 
& Brink, 2005). The strength of this relationship may suggest the need for services to develop a carefully 
calibrated stepped-care approach, focusing RQWUHDWLQJDQLQGLYLGXDO¶Vimmediate addiction needs supported by a 
package developing recovery strengths (Maremmani et al, 2006). The findings confirm variables associated with 
continued use include injecting status (Darke et al, 2005), ongoing drinking (Heidbrecht et al, 2018) and a 
relationship with quality-of-life (Best et al, 2011a; 2011b; Donovan et al, 2005). The correlation between age 
and abstinence is shown in the wider desistance literature in that involvement in illicit activities are predicted by 
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the ageing process (Kasemian, 2007) encompassing life transitions and experiences (Sampson & Laub, 1993), 
although this has been shown to be moderated by ongoing opiate use (Pierce et al, 2015).   
 
The findings confirm the importance of developing recovery strengths as means to curtailing illicit drug use, 
although the causal ordering of this effect cannot be assessed using current data. &RPSDUHGWR%UHZHU¶VPHWD-
analysis (1998), no association was noted with unemployment which may be due to large numbers of the 
treatment population being recorded as unemployed or economically inactive.  The association between 
coexisting problems (which was driven by psychological needs as one of its subdomains) and abstinence may be 
considered counter intuitive as psychological distress has been theorised to IRUP ³QHJDWLYH´ UHFRYHU\ FDSLWDO 
(Cloud & Granfield, 2008). Prevalence rates for psychological disorders are known to be high among those with 
substance use issues (Marsden et al, 2000) and dual diagnosis issues have been shown to result in lower 
acceptance and adherence to treatment programmes, often resulting in poorer treatment outcomes including 
relapse (Chung, 2005; Grella et al, 2001; Winters, 1999; Kaminer et al, 1992).  
 
Although there is evidence that mental health disorders may precede drug use (Shivola et al, 2008), there may be 
a link between increased psychological need for those in treatment due to prior drug use causing withdrawal 
symptoms (Alaja et al, 1997) and withdrawal psychosis (Levinson et al, 1994). An Australian longitudinal 
cohort study of heroin users in treatment found abstinence was also correlated with elevated levels of 
psychological distress (Darke et al, 2007). The authors speculated that psychological distress was used a 
motivator for behavioural changes including becoming drug free.   
 
This study offers a unique opportunity to XQGHUVWDQGVHUYLFHXVHUV¶KROLVWLFQHHGVDGGLFWLRQVHYHULW\FRH[LVWLQJ
health and social problems and recovery strengths) based on a validated assessment schedule using practitioner 
perspectives of their caseload combined with self-report data. Practitioner perspectives offer objective and 
accurate assessments RIDQLQGLYLGXDO¶VKROLVWLFQHHGV based on the strength of the therapeutic relationship and 
allowing for comparisons to be made across a caseload. This will ensure consistency in establishing the severity 
of clinical or social needs.  There is also an opportunity to further develop and refine the findings using more 
focused tools that examine the relationship with the other prognostics shown in this study. For example, more 
work is required to understand the association between mental health issues, engagement in treatment and 
receipt of MAT with concurrent use.  
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5. Strengths and Limitations 
 
Few UK studies have focused on the relationship between concurrent illicit drug use and engagement in MAT. 
This study provides an overview of holistic and recovery-focused factors that are associated with concurrent use 
of opiates and crack/cocaine whilst in MAT. The large cohort size with no missing or unknown cases enhance 
the utility of the data collected.  Information collected as part of the care-planning process enhances is based on 
the strength of the worker-client relationship and offers a unique assessment into the complex nature of an 
indivLGXDO¶VQDUUDWLYHZKLOVWLQUHFHLSWRI0$7 
 
The study also has some limitations. Firstly, the study was based on a single location within one English mixed 
rural/urban County Council area rather than a multicentre study. Secondly, whilst the study demonstrates 
statistical associations between concurrent illicit drug use and a range of prognostic variables, it is limited in 
terms of its explanatory capacity, as certain key variables were not available including dose levels. Finally, 
ADAPT and NDTMS/TOP were opportunistically matched EDVHG RQ WKH WUHDWPHQW VHUYLFHV¶ 12-week review 
process rather than assessing measures over a longer time period (for example, at six months or beyond).  
 
6. Concluding Remarks 
 
This study highlights the extent and nature of concurrent illicit opiate and cocaine use among individuals in 
receipt of MAT. Our findings suggest there are opportunities for developing coherent and tailored responses that 
situate concurrent use within a recovery-orientated approach. Interventions aimed at addressing concurrent Class 
A use whilst in receipt of MAT therefore should consider a stepped-care approach that focuses on managing 
substance misuse (urges and control, supporting reductions in injecting and alcohol consumption) that is age-
specific (e.g. calibrated towards younger service users). This approach should be augmented by interventions 
HQKDQFLQJDQLQGLYLGXDO¶VUHFRYHU\VWUHQJWKVVXSSRUWLQJSV\FKRORJLFDOQHHGVWRVXVWDLQDQLPSURYHGTXDOLW\-of-
life within an integrated package of care. 
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TABLES  
 
Table 1: Socio-Demographic & Treatment-referral Profile of Participants receiving MAT (n=776) 
 
Client Characteristics Number Percentage 
Gender   
- Male 563 73% 
- Female 213 27% 
Ethnic Group   
- White  719 93% 
- Non-White 57 7% 
Referral Route   
- Self 459 59% 
- Criminal Justice 147 19% 
- Other 170 22% 
 Mean Age/Range Standard Deviation 
Age 40.7 years (19-70 years) 7.89 
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Table 2: ADAPT Domain Group Strata, (n=776) 
 
 Addiction Severity Coexisting Health and Social Problems Recovery Strengths 
 Number Percentage Number Percentage Number Percentage 
Low 320 41% 394 51% 324 42% 
Moderate 311 40% 234 30% 313 40% 
High 145 19% 148 19% 139 18% 
 
 
  
2 
 
 
Table 3: Association between ADAPT and TOP measures and being abstinent from Opiate and/or 
crack/cocaine: logistic regression (n=776) 
 
 Odds 
Ratio 
P>[z] 95% Confidence Interval 
Addiction Severity Rank    
1. Low 12.55 0.000 [6.49, 24.27] 
2. Moderate 2.49 0.006 [1.30, 4.77] 
3. High 1 (base)   
Recovery Strengths Rank    
1. Low 1 (base)   
2. Moderate 1.37 0.143 [0.90, 2.10] 
3. High 2.30 0.004 [1.30, 4.07] 
Health and Social Complexity 
Rank 
   
1. Low 1 (base)   
2. Moderate 1.91 0.004 [1.23, 2.96] 
3. High 2.20 0.008 [1.23, 3.92] 
Abstain from Alcohol (TOP)    
No 1 (base)   
Yes 1.55 0.027 [1.05, 2.30] 
Abstain from Injecting (TOP)    
No 1 (base)   
Yes 2.38 0.02 [1.15, 4.93] 
Quality of Life 1.05 0.039 [1.00, 1.10] 
Age 1.03 0.004 [1.01, 1.06] 
 
  
2 
 
Table 4: Effect sizes and p-values for dichotomous outcome (14 ADAPT subdomains) 
 
 Odds 
Ratio 
P>[z] 95% Confidence Interval 
Urge and Control    
None 27.45 0.000 [13.18, 57.16] 
Low 5.61 0.000 [2.86, 11.00] 
Moderate 1.20 0.605 [0.60, 2.43] 
High 1 (base)   
Psychological Health    
None 1 (base)   
Low 2.00 0.002 [1.29, 3.10] 
Moderate 2.97 0.000 [1.67, 5.29] 
High 5.36 0.039 [1.09, 26.36] 
Abstain from Injecting (TOP)    
No 1 (base)   
Yes 2.58 0.014 [1.21, 5.49] 
Quality of Life 1.06 0.009 [1.02, 1.11] 
Age 1.03 0.026 [1.00, 1.05] 
 
 
